Outset Medical Inc (OM) — Titan Protect Analysis

Outset Medical Inc

Healthcare · ·

$4.58

Data: 2026-06-03

✓ ETHICAL PASS

NONE MOAT

LIMITED

Data Confidence: 0.0%

Key Metrics

How this company measures up on the fundamentals that matter

Market Cap

$93M

Total market value of the company

Trailing P/E

N/A

Forward P/E

-2.30

Based on estimated future earnings — lower means cheaper

Rev Growth

-6.3%

Year-over-year revenue change

Profit Margin

-63.7%

How much profit the company keeps from each dollar of revenue

ROE

-53.2%

Return on equity — how efficiently it uses shareholder money

Analyst Target

$8.00

+75% from current price — median analyst estimate

Recommendation

BUY

Consensus view from 3 analysts covering this stock

About Outset Medical Inc

Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company provides Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also offers Tablo Data Ecosystem, including TabloHub, a consumer-facing p

https://www.outsetmedical.com

Country: United States Employees: 310 Industry: Medical Devices

Ethical Screening

Five compliance checks based on AAOIFI standards — all must pass for ethical clearance

Business Activity

PASS

Core business does not involve prohibited activities

Debt Ratio

0.0% PENDING

Debt must be below 33% of total assets

Cash Ratio

0.0% PENDING

Interest-bearing cash below 33% of assets

Receivables

0.0% PENDING

Receivables below 49% of assets

Revenue Purity

0.0% PENDING

Non-compliant revenue below 5% — any excess requires purification

Quantitative Intelligence

Statistical analysis of price behaviour, risk, and market regime — independent of fundamental data

Regime

MARKUP

Price trending up with increasing momentum

Sharpe Ratio

-0.378

Returns do not compensate for the risk — negative edge

Kelly Fraction

-0.0533

No positive edge detected — the data suggests staying out

Calmar Ratio

-0.757

Drawdown risk outweighs the returns — higher risk profile

Annual Return

-72.4%

Historical annualised return based on price data

Max Drawdown

-95.6%

Largest peak-to-trough decline — the worst it has been

HMM State

BULL

Statistical model sees bullish momentum

Days in State

How long the current regime has persisted — longer means more stable

Market Data

Trading characteristics and market positioning

Beta

1.91

Significantly more volatile than the market

52W High

$21.98

79% below the year high

52W Low

$3.00

53% above the year low

Avg Volume

171,179

Average daily shares traded — higher means easier to buy and sell

Short Ratio

12.0

Days it would take all short sellers to cover — higher means more crowded

Short % Float

N/A

Div Yield

N/A

Annual dividend as a percentage of the share price

EPS (TTM)

$-2.74

Earnings per share over the last 12 months

Financial Health

Balance sheet strength and cash generation — the foundation of long-term value

Debt/Equity

90.98

Heavy leverage — higher financial risk if revenues decline

Current Ratio

N/A

Quick Ratio

N/A

Like current ratio but excludes inventory — stricter test

Gross Margin

40.6%

Revenue left after cost of goods — higher means pricing power

Operating Margin

-60.7%

Profit from core operations before interest and tax

Free Cash Flow

$-10,455,875

Negative — the business is spending more than it generates

Revenue (TTM)

$118M

Total revenue over the last 12 months

Net Income

$-74,848,000

Loss-making — spending exceeds revenue after all costs

Analyst Coverage

Analysts

Target High

$10.00

Target Median

$8.00

Target Low

$7.00

Political Trading Activity

Congressional trading disclosures involving this instrument

Date	Politician	Party	Type	Amount
9 Apr2026	Josh Gottheimer	Democrat	sell	15K–50K
9 Apr2026	Josh Gottheimer	Democrat	sell	15K–50K
7 May2026	Sara Jacobs	Democrat	sell	500K–1M
7 Feb2025	Tim Walberg	Republican	buy	1K–15K
7 Feb2025	Tim Walberg	Republican	buy	15K–50K

Source: Congressional disclosure filings. View all political trades at

Insider Intelligence

Explore the Ethical Screener View Track Record

Data sourced from public filings and market feeds. Not financial advice. Updated: 2026-06-03

Before you go